Company / Current Assets per Share
Nurix Therapeutics, Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$8.00
FY2025
5-year range
$6.26 / $12.71
FY2021-FY2025
Trend
-37.1%
vs FY2024
Sector context
#93 of 210
Health Care
What the data says
At $8.00, Nurix Therapeutics, Inc.'s current assets per share ranks #93 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 7 years, ranging from $6.26 in FY2023 to $83.01 in FY2020.
Based on SEC 10-K filings.
8.00 in FY2025 with a 5-year CAGR of -37.4%.
Improved from $6.26 to $8.00 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.9%
- 5-Year CAGR
- -37.4%
- 10-Year CAGR
- -
Sector benchmark
#93 of 210 in Health CareTop 44% of 210This company $8.00 Sector average $134.38
▼
-94.0% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 37.1% year-over-year.
- Ranks #93 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.00 | -37.1% |
| FY2024 | $12.71 | +103.0% |
| FY2023 | $6.26 | -12.1% |
| FY2022 | $7.13 | -10.9% |
| FY2021 | $8.01 | -90.4% |
| FY2020 | $83.01 | +594.5% |
| FY2019 | $11.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026